Metalloproteinase inhibitors
US6124332A · kind A · utility
3Cited by
2References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 1999 |
| Grant date | Sep 26, 2000 |
| Priority date | — |
| Expiry date | Feb 3, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutically active hydroxamic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, and the use of such compounds in medicine. The compounds are inhibitors of metalloproteinases involved in tissue degradation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.